NORTHROP GRUMMAN CORP /DE/
At today's price, NORTHROP GRUMMAN CORP /DE/ (NOC) is priced for +3.0% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Northrop Grumman is a defense prime that turns a record $95.7B backlog into revenue: roughly 60% of that backlog converts within 24 months, and the customer is overwhelmingly one buyer, the U.S. government, where each segment ⟦derives a substantial⟧ share of sales. • The defining risk is fixed-price development: the B-21 program already cost a $1.56B projected loss recognized in 2023, and a production ramp now carries another $2.5B of company-funded capacity investment that pressures near-term
Is NOC overvalued? See what's priced in →
1,836 institutional managers reported holding NOC in 13F filings for the quarter ended 2026-03-31. Together they hold about 82% of the company; the top 10 hold 49%. 199 opened new positions that quarter. Held by Vanguard Group, State Street, BlackRock, among others. On the short side, 2.1M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
NOC has cut its share count 11.7% over the past five years, spending $8.77B on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting), raised 17 years straight; the current rate is $8.99 a share annually. Cash returned over the past three years: $3.37B in dividends and $4.78B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at NOC over the trailing three years. Absence is a fact about the company, not a signal. 22 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
NOC's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-28 | -1.6% | -2.1% |
| 2023-10-27 | -2.1% | -1.0% |
| 2024-01-26 | -5.6% | +9.3% |
| 2024-04-26 | +1.2% | -9.3% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
NOC's latest 8-K filings: 2026-05-21 (items 5.07); 2026-04-21 (items 2.02, 9.01); 2026-02-13 (items 5.02, 9.01); 2026-01-27 (items 2.02, 9.01); 2025-11-06 (items 5.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.